Personalized Tumor Therapy

Scientists at the Regensburg site of Fraunhofer ITEM have extensive expertise in the detection, isolation, and analysis of rare cell populations as well as small amounts of nucleic acids.

Our goal is to advance targeted diagnostics for prevention and therapy for patients with systemic cancers and to improve the preclinical development of new pharmaceutical compounds.

For example, we use Multiomics analysis of single cells and innovative preclinical cell models from patient samples acquired from specific projects for the purpose of generating molecular and functional data. In addition, our GDPR-compliant data management and in-house bioinformatics enable tailored data analysis for developing applications and products for our customers.